Delivery Order SPE2DR25D2011-SPE2DR26FADKX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,869.09 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 50 mg tablets (60-count). This competitively awarded, firm fixed-price contract requires delivery by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 100 mg tablets (60-count units) valued at $1,146.40 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of November 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,975.11 to AmerisourceBergen Drug Corp for the supply of Briviact 75 mg tablets (60-count units) on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,741.46 to AmerisourceBergen Drug Corp for the supply of Briviact 75 mg tablets (60-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.46 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units). The contract, which is not set-aside and utilizes firm fixed pricing, was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,004.05 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $21,354.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Briviact 75 mg tablets (60-count units). The contract, which is classified as a child award with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADKXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,704.14 to AmerisourceBergen Drug Corp for the supply of Briviact 75 mg tablets (60-count units). This competitively awarded, firm fixed-price contract was executed on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating the contract was competed among all eligible vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad spectrum of medications and medical commodities to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/23/25 |